These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 33809527)
1. Mechanisms of Neurodegeneration in Various Forms of Parkinsonism-Similarities and Differences. Koziorowski D; Figura M; Milanowski ŁM; Szlufik S; Alster P; Madetko N; Friedman A Cells; 2021 Mar; 10(3):. PubMed ID: 33809527 [TBL] [Abstract][Full Text] [Related]
2. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119 [TBL] [Abstract][Full Text] [Related]
3. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related]
5. An overview of parkinsonian syndromes: data from the literature and from an Italian data-base. Pezzoli G; Canesi M; Galli C Sleep Med; 2004 Mar; 5(2):181-7. PubMed ID: 15033141 [TBL] [Abstract][Full Text] [Related]
6. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810 [TBL] [Abstract][Full Text] [Related]
13. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity. Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439 [TBL] [Abstract][Full Text] [Related]
14. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms. Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435 [TBL] [Abstract][Full Text] [Related]
15. The genetics of disorders with synuclein pathology and parkinsonism. Farrer M; Gwinn-Hardy K; Hutton M; Hardy J Hum Mol Genet; 1999; 8(10):1901-5. PubMed ID: 10469843 [TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility variants in parkinsonism. Soto-Ortolaza AI; Ross OA Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118 [TBL] [Abstract][Full Text] [Related]
18. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception. Moda F; Ciullini A; Dellarole IL; Lombardo A; Campanella N; Bufano G; Cazzaniga FA; Giaccone G Front Biosci (Landmark Ed); 2023 Oct; 28(10):255. PubMed ID: 37919089 [TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Orimo S Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]